Arformoterol Tartrate Solution
Product Images NDC 43598-777

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 43598-777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

An instructional illustration showing a hand holding a vial of medication, with an arrow indicating a twisting motion to open the vial. This likely depicts how to prepare the arformoterol tartrate inhalation solution for use.*

FDA Label Image

Figure2 (Figure2)

An instructional illustration showing a hand holding a tube, squeezing its contents into a labeled reservoir, likely demonstrating the correct method to add solution to a respiratory inhalation device reservoir.*

FDA Label Image

Figure3 (Figure3)

An instructional diagram illustrating the assembly of a mouthpiece onto a respiratory inhalation device, likely related to arformoterol tartrate inhalation solution. The image shows the mouthpiece positioned near the device, indicating how it should be attached for use.*

FDA Label Image

Figure4 (Figure4)

An instructional illustration depicting a face mask connected to a respiratory inhalation device, indicating usage with the solution labeled as arformoterol tartrate.*

FDA Label Image

Figure5 (Figure5)

An instructional illustration showing a segment of a compressor machine labeled 'COMPRESSOR' connected by a tube labeled 'TUBING'. The image highlights the connection point where the tubing attaches to the compressor device, likely related to respiratory inhalation equipment.*

FDA Label Image

Figure6 (Figure6)

An instructional illustration showing a person using an inhalation device. The person places the mouthpiece of the inhaler in their mouth, demonstrating the proper use technique for administering the medication by respiratory inhalation.*

FDA Label Image

Carton30s (Carton30s)

Packaging label for arformoterol tartrate inhalation solution, 15 mcg per 2 mL. The label indicates the product is for oral inhalation only and comes in 30 sterile unit-dose vials. It also includes storage instructions to keep refrigerated or store at room temperature for up to 6 weeks. The labeler is Dr. Reddy's Laboratories, Inc. and the NDC is 43598-777-30.*

FDA Label Image

Carton60s (Carton60s)

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL carton packaging shows the respiratory inhalation solution by Dr. Reddy's Laboratories, Inc. The label indicates 60 2 mL sterile unit-dose vials (15 x 4 unit-dose vials per pouch), with details on storage instructions to keep refrigerated or at room temperature for up to 6 weeks and prescription-only status.*

FDA Label Image

Figure-1-week-0 (Figure 1 Week 0)

A line chart depicting mean change from baseline FEV1 (L) over 12 hours postdose comparing placebo and 15 mcg arformoterol tartrate BID. The x-axis represents hours postdose (0 to 12), and the y-axis shows mean change in FEV1. Data points and lines illustrate the respiratory function response for both groups as postdose time progresses.*

FDA Label Image

Figure-2-week-12 (Figure 2 Week 12)

A line graph showing mean change from baseline FEV1 (L) over 12 hours postdose. Two data series are plotted: placebo and 15 mcg arformoterol tartrate BID, with baseline FEV1 values indicated. The graph compares lung function changes between the placebo and the arformoterol tartrate treatment groups.*

FDA Label Image

Logo (Logo)

FDA Label Image

Pouchlabel1s (Pouchlabel1s)

Label for arformoterol tartrate 15 mcg/2 mL inhalation solution by Dr. Reddy's Laboratories, Inc. The label includes dosing strength, dosage form (solution), route of administration (respiratory inhalation), storage instructions, handling warnings, and distributor information. Barcode and NDC 43598-777-11 are visible. The label is designed for a single 2 mL unit-dose vial.*

FDA Label Image

Pouchlabel4s (Pouchlabel4s)

Label for arformoterol tartrate inhalation solution 15 mcg/2 mL by Dr. Reddy's Laboratories, Inc. The label includes usage instructions, storage conditions, an expiration date of 04/2023, a barcode, NDC 43598-777-48, and distribution details stating it is made in India and distributed from Princeton, NJ. The label cautions to use only as directed and not to exceed the recommended dosage.*

FDA Label Image

Structural-formula (Structural Formula)

Chemical structure diagram of arformoterol tartrate, showing the molecular arrangement of the active ingredient alongside the tartrate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.